Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Atroposelective synthesis of sterically hindered stereochemically complex BINOL derivatives via central-to-axial chirality induction

Yang Yang a, Guishun Bai a, Mengmeng Qin a, Juelian Wang a, Yihuan Yang a, Hong Wang *ac, Damien Bonne *b, Jean Rodriguez b and Xiaoze Bao *ac
aCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China. E-mail: hongw@zjut.edu.cn; baoxiaoze@zjut.edu.cn
bAix Marseille Univ, CNRS, Centrale Med, iSm2, Marseille, France. E-mail: damien.bonne@univ-amu.fr
cZhejiang International Sci-Tech Cooperation Base for the Exploitation and Utilization of Natural Product, Hangzhou 310014, China

Received 13th July 2025 , Accepted 10th September 2025

First published on 22nd September 2025


Abstract

A sequential strategy is proposed for the atroposelective construction of new families of sterically hindered BINOL derivatives bearing multiple stereogenic elements and featuring up to four stereogenic centers. The sequence begins with an organocatalyzed regio- and enantioselective mono-dihydrobenzofurannulation of commercially available 2,7-dihydroxynaphthalene establishing two stereogenic carbon atoms, followed by highly atroposelective copper-catalyzed aerobic oxidative homo- or cross-couplings fixing the axial chirality thanks to a nearly perfect induction of chirality. In addition, the resulting BINOL derivatives serve as promising precursors for the synthesis of either complex spiroheterocycles by axial-to-central conversion of chirality, heterohelicene-like molecules by axial-to-helical conversion of chirality, or an atropisomeric naphtho[2,1-b]furan scaffold via 1,2-aryl migration, further underscoring the potential of this new atroposelective strategy based on a practical central-to-axial chirality induction.


Introduction

The preparation of optically active BINOL derivatives is extremely important in organic chemistry, owing to their widespread applications in enantioselective catalysis, chiral recognition, and the development of optical materials.1–6 In recent years, the advances in enantioselective oxidative coupling have led to the development of elegant methodologies for the synthesis of optically active BINOL derivatives.7 Typically, Cu(II),8–12 V(V),13–17 Fe(III)18–21 and Ru(IV)22,23 coordinated with suitable chiral ligands are used as catalysts, as well as more recently in electrochemical cross-couplings.24,25 Therefore, the synthesis of optically active chiral BINOL derivatives remains a very attractive area of research.26–29

Among various derivatives, the 8,8′-disubstituted BINOL family is distinctive due to its pronounced steric hindrance.30,31 This leads to a greater dihedral angle and a more restricted rotation around the axis, making them key precursors for the construction of helically chiral compounds.32–40 As shown in Scheme 1a, chiral helicenoids constructed from sterically hindered 8,8′-disubstituted BINOL derivatives exhibit excellent photoelectric properties and catalytic performance.33–36 Moreover, helical structures are of great importance in areas such as molecular recognition and circularly polarized luminescence (CPL).37–43 However, unlike the thriving development of the synthesis of other axially chiral biaryls, the stereoselective construction of highly sterically hindered 8,8′-disubstituted BINOL derivatives has remained relatively underexplored, probably due to the challenges associated with the difficulty of achieving high stereocontrol in such congested systems. As depicted in Scheme 1b, the current strategies involve either using simple achiral 8-substituted naphthol precursors, followed by oxidative coupling and chiral resolution,33–35,40–42 or direct enantioselective oxidative couplings.44,45 The former strategy is the most widely used but is time-consuming and labor-intensive, and the latter has only sporadic reports and faces limitations such as low enantiomeric excess or the need for additional coordinating groups. It is speculated that the changes in reactivity brought by the remote steric hindrance may impose higher requirements on the enantioselective catalytic system. In contrast to previous strategies, we design herein a catalytic atroposelective synthesis via a central-to-axial chirality induction strategy. This approach pioneered by Meyers in 1982 has been only utilized to date in several specific cases with modest to good atroposelectivities.46–51 Here we propose the generation of the key centrally chiral 2-naphthol precursor through a regio- and enantioselective functionalization of phenols followed by an atroposelective oxidative coupling reaction triggering the stereogenic axis with chiral induction (Scheme 1b).


image file: d5sc05212b-s1.tif
Scheme 1 Application of steric hindrance in BINOL derivatives and their synthesis.

To implement this chirality induction strategy, cheap and commercially available 2,7-dihydroxynaphthalene 1 was selected as the starting material. Its two unique 1,8-reactive sites offer more opportunities for reaction design and the installation of a chiral moiety via enantioselective transformations. Building on our previous work,52–57 the key centrally chiral dihydrobenzofuran 3 could be constructed through an enantioselective domino Michael/O-alkylation reaction with α-chloronitroalkenes 2 (Scheme 1c). By controlling the reaction conditions and leveraging steric effects, we were able to ensure a totally regio- and enantioselective mono-functionalization. Subsequently, we hypothesized that by using commercially available Cu-TMEDA as the achiral oxidative coupling catalyst, either homo-coupling of the chiral intermediate 3 or cross-coupling with other naphthol derivatives could be insured in a high atroposelective manner. The success of this design would provide a new practical strategy for the preparation of sterically hindered 8,8′-disubstituted BINOL derivatives embedding various stereogenic centers that are otherwise difficult to access.58,59

Results and discussion

The initial endeavor of the domino Michael/O-alkylation process was conducted with 2,7-dihydroxynaphthalene 1a and α-chloronitroalkene 2a (Table 1). With bifunctional squaramide Cat. 1 as a catalyst, the desired product 3aa was obtained in 76% yield with 88% ee and over 20[thin space (1/6-em)]:[thin space (1/6-em)]1 dr in the presence of dipotassium hydrogen phosphate trihydrate as an inorganic base (entry 1). THF was added to enhance the solubility of 2,7-dihydroxynaphthalene 1a, suppressing the second cyclization process. In order to further improve the yield and enantioselectivity, both low temperature and low concentrations were beneficial for this transformation (entries 2–7). Finally, in a highly diluted solution (0.003 M) at −20 °C, 3aa was afforded in 96% yield with 94% ee (entry 7). In addition, the efficiency remained unchanged on a 1 mmol scale (entry 8). To simplify the process, 3aa was used directly after short flash chromatography to remove the excess amount of 2,7- dihydroxynaphthalene, the catalyst and the inorganic base. To our delight, the atroposelective homocoupling was successful after a quick survey of oxidation catalysts (see Table S1 for details). With 5 mol% of commercially available di-m-hydroxo- bis[(N,N,N′,N′-tetramethylethylenediamine)copper(II)] chloride (Cu-TMEDA) as a catalyst and air as a green oxidant, the desired C2- symmetric BINOL derivative 4aa featuring four stereogenic centers was obtained in 78% yield (for 2 steps) with 99% ee and, most importantly, as a single diastereomer (>20[thin space (1/6-em)]:[thin space (1/6-em)]1 dr, entry 9). The improvement of enantiomeric excess (96 to >99% ee) clearly indicated the beneficial role of the Horeau chiral amplification principle and the efficiency of central-to-axial chirality induction.60,61 In addition, the importance of air was also proved, as the yield was dramatically decreased under an argon atmosphere, indicating that the combination of Cu-TMEDA and air is a practical catalytic system for oxidative cross-coupling of highly sterically hindered phenol derivatives.
Table 1 Optimization of the reaction conditions for chirality inductionab

image file: d5sc05212b-u1.tif

Entry Conc. (M) T (°C) Yield of 3ac (ee) Yield of 4ac (ee)
a Unless otherwise noted, reactions were conducted with 1a (0.3 mmol), Cat. 1 (10 mol%), 2a (0.2 mmol) and base (0.4 mmol) in solvent. b Isolated yield. c Determined by HPLC on a chiral stationary phase. d 1a (1.5 mmol) and 2a (1 mmol). e Yield for 2 steps. f Under an argon atmosphere.
1 0.10 25 76 (88)
2 0.05 25 71 (90)
3 0.05 0 69 (93)
4 0.025 0 77 (94)
5 0.015 0 81 (94)
6 0.025 −20 69 (96)
7 0.003 −20 96 (94)
8d 0.003 −20 96 (94)
9 0.003 −20 96 (94) 78 (99)
10f 0.003 −20 96 (94) 10e (99)


With optimized reaction conditions in hand, the generality of this chirality induction process was explored (Scheme 2). The tolerance of the α-chloronitroalkenes was investigated, revealing that both electronic and steric parameters influenced the reactivity, but with a uniform excellent double stereocontrol. The influence of para-substituents on the aryl group was first studied. It was found that halogen substitution could lead to good yields (4ab–4ad, 56–70% yield for 2 steps). Electron-donating substituents such as methyl (4ae) and methoxy (4af) groups were also tolerated well. When the para-position was substituted with an ester group (4ag), the yield decreased significantly, although the stereocontrol of the reaction was still good. The results of meta-substitutions were similar to those of para-substituted ones. Except for the chloro substitution (4ai), the products all achieved good yields (4ah and 4aj–4am). When examining the substituent effect at the ortho-position, the steric effect played an important role. As expected, the bromo group (4ap) with the largest steric hindrance gave the lowest yield. Other groups with relatively smaller steric hindrance all achieved moderate yields (4an, 4ao, and 4aq–4at). In addition, heterocyclic substituents such as furan (4au), thiophene (4av), and benzothiophene (4aw) were all suitable, with the highest isolated yield of 84%. In addition to the aryl substituted chloronitroalkene, the alkenyl substituted counterpart also furnished the desired product 4ax in 31% yield with 8[thin space (1/6-em)]:[thin space (1/6-em)]1 dr and 99% ee. Intriguingly, during the preparation of the alkynyl substituted chloronitroalkene, an additional hydrochlorination reaction of the carbon–carbon triple bond was observed. Under the optimized reaction conditions, the (3 + 2) cyclized product 3ay was successfully isolated in 67% yield and 86% ee. However, the oxidative coupling product 4ay remained undetected. Regrettably, the cyclohexyl substituted chloronitroalkene proved unable to undergo the initial (3 + 2) cyclization process. Furthermore, the 3,6-disubstituted 2,7-dihydroxynaphthalenes were also subjected to testing. The dibromo substituted cyclized product 3ba was obtained in 90% yield with 84% ee. The coupling process was halted, presumably due to the steric hindrance and electron-withdrawing nature of the bromine atoms. Moreover, the diphenyl substituted 2,7-dihydroxynaphthalene was found to be incompatible with the cyclization process. The absolute configuration of 4ad was determined to be aR by single crystal X-ray crystallographic analysis, and the configurations of the other compounds were assigned by analogy.62


image file: d5sc05212b-s2.tif
Scheme 2 Evaluation of substrate scope of homo-coupling. aConducted on a 0.2 mmol scale, yield was reported for 2 steps, and 3 was used directly after flash chromatography.

After achieving excellent chirality induction in homo-coupling, we wondered whether the cross-coupling reaction between chiral intermediates 3 and 2-naphthols 5 would be chemo- and stereoselective, as less hindered 2-naphthol may undergo self-coupling more easily. After the optimization of a series of reaction conditions, it was discovered that in acetonitrile, the Cu-TMEDA complex was also capable of facilitating the targeted selective cross-coupling reaction (see TS-2 in the SI). When 2.0 equivalents of 2-naphthol 5a were present, the homo-coupling of 3aa was effectively inhibited. As a result, the sterically hindered non-C2 symmetric BINOL derivative 6aa was obtained in 65% yield and 93% ee (Scheme 3). Under these reaction conditions, 4aa and BINOL (calculated based on 5a) were isolated in 18% yield and 41% yield, respectively. Subsequently, a preliminary investigation of the substrate adaptability was carried out. Products with 3-methoxy (6la) and 4-nitro (6ga) substitutions on the aromatic ring of the nitroalkene moiety could be obtained with moderate yields and excellent ee values. For heterocyclic substitutions, such as benzothiophene (6wa) and furan (6ma), the yields of the products decreased slightly. In addition, the substituents on the 2-naphthol moiety also had less influence. For example, products with bromo (6ab) and formyl (6ac) substitutions at the 6-position, as well as methoxy (6ad) and bromo (6ae) substitutions at the 7-position, all showed good stereoselectivities in moderate yields. These preliminary results along with the adaptability of substituents indicate that chiral induction is also effective to construct more challenging non-C2-symmetric BINOL derivatives.


image file: d5sc05212b-s3.tif
Scheme 3 Evaluation of substrate scope of cross-coupling. aConducted on a 0.2 mmol scale. bYield was reported for 2 steps.

With the preparation of a series of sterically hindered BINOL derivatives, we attempted to transform them into the corresponding [7]-oxa-helicenes 7.63,64 However, in the presence of a stoichiometric amount of p-toluenesulfonic acid (TsOH) in refluxing toluene, the expected heterohelicene 7aa was not observed. Surprisingly, the rearranged spirocyclic lactone 8aa featuring five stereogenic centers was isolated in 16% yield instead.65 After a series of investigations (Table 2, entries 2–6, Tables S3–S5 in the SI), it was found that a catalytic amount (20 mol%) of stronger trifluoromethanesulfonic acid (TfOH) could afford the rearranged product 8aa in 87% yield and 99% ee, via a rare example of axial-to-central chirality conversion.66–73 In addition, ferric chloride as a Lewis acid catalyst could also promote this reaction, affording product 8aa in 66% yield (entry 7). Subsequent investigations revealed that dichloromethane was the best solvent and air was essential for this rearrangement to proceed (entries 8–10).

Table 2 Optimization of the reaction conditions for the synthesis of spiro-cyclic productsa

image file: d5sc05212b-u2.tif

Entry Cat. Solvent T (°C) Yield of 8aab
a Unless otherwise noted, reactions were conducted with 4aa (0.1 mmol) and Cat. (20 mol%) in solvent. b Isolated yield. c 100 mol% of Cat. was used. d Under Ar.
1c TsOH·H2O Toluene 120 16
2c TsOH·H2O Toluene 25 0
3c TsOH·H2O DCM 25 0
4c CH3SO3H DCM 25 9
5c TfOH DCM 25 Complex
6 TfOH DCM 25 87
7 FeCl3 DCM 25 66
8 TfOH MeOH 25 0
9 TfOH CHCl3 25 Trace
10d TfOH DCM 25 Trace


Similarly, a preliminary investigation on the substrate adaptability of this peculiar rearrangement with axial-to-central chirality conversion was conducted. Overall, the rearranged products could be obtained in good yields with consistently excellent enantiomeric excesses (Scheme 4). Halogen substitutions at the para-position of the aromatic ring were well-tolerated, and the target products 8ab–8ad were obtained in 68–85% yields. For the electron-donating methyl substitution, the yield of the product (8ae) was 80%. The product with a meta-methoxy substitution (8al) could be obtained with a moderate 35% yield but still with nearly perfect enantioselectivity (99% ee). In addition, products with meta-halogen substitutions (8ah–8aj) could also be obtained in good yields. For heterocyclic substitutions, illustrated as thiophene (8av) and benzothiophene (8aw), the yields of the products decreased to 45% and 35%, respectively but the ee remains high. The absolute configuration of the product 8aa was determined by single crystal X-ray crystallographic analysis, and others were assigned by analogy.62


image file: d5sc05212b-s4.tif
Scheme 4 Evaluation of substrate scope of spiro-cyclic products. aConducted on a 0.2 mmol scale.

To explain the chirality induction process in BINOL derivatives 4 and 6 and the subsequent oxidative rearrangement with axial-to-central chirality conversion to spiro lactones 8, a possible reaction pathway is proposed in Scheme 5. First, in the presence of bifunctional squaramide Cat. 1, hydrogen-bonding activation of both substrates 1a and 2a results in the transition state TS-1 triggering enantioselective Michael addition to yield the adduct 9. Subsequently, in the presence of the inorganic base, further O-alkylation is promoted to obtain the key centrally chiral dihydrobenzofuran 3aa, with trans relative configuration. The remaining 2-hydroxynaphthalene moiety in 3aa can be oxidized by Cu(II) to generate the radical intermediate 10; meanwhile, another molecule of 3aa can undergo ligand exchange to form intermediate 11. In the subsequent C–C bond coupling step, two possible transition states, TS-2 and TS-3, can be envisioned. However, TS-2 involves significant steric hindrance between the two chiral dihydrobenzofuran moieties, making it energetically unfavorable. Therefore, the final oxidative coupling product 4aa is obtained via a series of single-electron transfers through the more favorable transition state TS-3. The released Cu(I) can be oxidized to Cu(II) by oxygen to terminate the catalytic cycle. In addition, in the presence of a strong Brønsted acid, the tautomerized intermediate 12 can be generated in situ and trapped by intramolecular addition to generate the hemiacetal intermediate 13 whose dehydration leading to oxa-helicene 7aa is hampered for steric reasons. Therefore, the presence of dioxygen can promote the oxidation of 13 to the highly reactive oxonium ion intermediate 14, triggering a 1,2-migration of the alkenyl part to yield the rearranged spirocyclic lactone 8aa.


image file: d5sc05212b-s5.tif
Scheme 5 Proposed mechanistic pathways.

To further demonstrate the utility of this strategy, 2,3-dihydroxynaphthalene 15 was used as the starting material. Under standard conditions, the homo-coupled 3,3′-difunctionalized BINOL derivative 16 was obtained in 74% yield with 99% ee (Scheme 6). Although the atroposelectivity is modest (dr = 2[thin space (1/6-em)]:[thin space (1/6-em)]1), the two atropisomers bearing four stereogenic centers could be separated by column chromatography. When 2,6-dihydroxynaphthol 17 was used, the BINOL derivative 18 was obtained in 78% yield with low atroposelectivity (dr = 1[thin space (1/6-em)]:[thin space (1/6-em)]1) and 99% ee (Scheme 6). To account for this disparity in comparison with the high atroposelectivity exhibited by 4aa, the corresponding transition states of the oxidative coupling process were postulated. As depicted in Scheme 6, within Ts-5, the two phenyl groups encounter steric hindrance. Consequently, TS-4 is preferred, leading to a diastereomeric ratio of 2[thin space (1/6-em)]:[thin space (1/6-em)]1 for compound 16. The closer proximity between both dihydrofuran moieties upon coupling as compared to the coupling leading to 4aa might explain the lower diastereoselectivity in this case. In contrast, in TS-6 and Ts-7, there is no steric hindrance since the chiral dihydrofuran moiety is situated at a higher distance from the coupling site. In consequence, almost no energy difference between TS-6 and TS-7 could account for the absence of diastereoselectivity in this case.


image file: d5sc05212b-s6.tif
Scheme 6 Application of 2,3- and 2,6-dihydroxynaphthalenes.

The post-transformation of the sterically hindered BINOL derivative 4aa was further investigated (Scheme 7a). First, mono-O-alkylated product 19 was obtained in 45% yield via a chemoselective Mitsunobu reaction preserving the stereochemical integrity. Similarly, the mono-triflate 20 was synthesized in 87% yield, which could be amenable to further cross-coupling reactions as needed. In the presence of tributyltin hydride, selective radical denitration gives the C2-symmetric centrally and axially chiral dihydrobenzofurane 21 in 39% yield and no erosion of the enantiopurity was observed. Interestingly, in the presence of BF3 and tetrachloro-1,4-benzoquinone (TCBQ), an unexpected aryl migration/aromatization reaction occurred, affording the atropisomeric naphtho[2,1-b]furan 22 in modest yield but with high stereocontrol.74,75 A possible mechanistic interpretation for this 1,2 aryl migration is shown in Scheme 7b. The nitrodihydrofuran moiety could be oxidized to form the oxonium ion intermediate, which is then trapped by the phenyl group to generate a phenonium ion to complete the 1,2-aryl migration after rearomatization. The absolute configuration of the product 22 was confirmed by single crystal X-ray crystallographic analysis.62 Moreover, in the presence of phenyldichlorophosphine oxide and triethylamine, an efficient axial-to-helical conversion of chirality occurred leading to the formation of heterohelicene-like molecule 23 in 96% yield. In addition, elimination of HNO2 from spirolactone 8aa obtained from BINOL 4aa occurred in acetic acid providing the curved molecule 24 with maintained enantiopurity.76 Finally, the heterohelicene-like P,N-ligand 25 was synthesized in the presence of hexamethylphosphinetriamine with maintained ee. The above synthetic post-transformations fully demonstrate the synthetic potential of the sterically hindered 8,8′-disubstituted BINOL derivatives obtained through central-to-axial chirality induction.


image file: d5sc05212b-s7.tif
Scheme 7 Post-functionalization reactions.

Conclusions

In summary, a highly atroposelective strategy for the synthesis of sterically hindered stereochemically complex 8,8′-disubstituted BINOL derivatives was developed through an efficient central-to-axial chirality induction. This process relies on a regio- and enantioselective mono-dihydrobenzofurannulation of commercially available 2,7-dihydroxynaphthalene controlling the central chirality, followed by a highly atroposelective copper-catalyzed aerobic oxidative coupling fixing the axial chirality and enabling access to new families of C2 and non-C2 symmetric BINOL derivatives featuring up to four stereogenic centers. In addition, simple post-transformations demonstrated the synthetic potential of these derivatives to access either spiroheterocycles by a rare axial-to-central conversion of chirality or heterohelicene-like or atropisomeric naphtho[2,1-b]furan compounds via intriguing rearrangement processes including a triple central-to-axial-to-helical conversion of chirality, which highlighted the versatility and synthetic utility of this new atroposelective methodology.

Author contributions

X. Bao and D. Bonne designed this project. Y. Yang, G. Bai, and M. Qin performed the chemical experiments and prepared the SI. Y. Yang and J. Wang participated in the preparation of the SI. J. Rodriguez and H. Wang supervised and directed the project. All authors discussed and participated in the preparation of the final manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

CCDC 2464854 (4ad), 2464855 (22), 2464856 (8aa) and 2464857 (24) contain the supplementary crystallographic data for this paper.62a–d

The data that support the findings of this study are available in the SI of this article, including the detailed experimental procedures, characterization data, and copies of the spectra of products (1H, 19F, 31P, and 13C NMR and HPLC). See DOI: https://doi.org/10.1039/d5sc05212b.

Acknowledgements

Financial support from the programs of the Young Scientists Fund of the National Natural Science Foundation of China (No. 22302176), the National Key Research and Development Program of China (No. 2022YFC2804104), the Agence Nationale pour la Recherche (ANR-21-CE07-0036), Aix Marseille Université and the Centre National de la Recherche Scientifique (CNRS) is gratefully acknowledged. We thank the Key Laboratory of Marine Fishery Resources Exploitment & Utilization of Zhejiang Province.

Notes and references

  1. J. M. Brunel, Chem. Rev., 2005, 105, 857–898 CrossRef PubMed.
  2. L. Pu, Chem. Rev., 2024, 124, 6643–6689 CrossRef PubMed.
  3. Y. Yu, Y. Hu, C. Ning, W. Shi, A. Yang, Y. Zhao, Z.-Y. Cao, Y. Xu and P. Du, Angew. Chem., Int. Ed., 2024, 63, e202407034 CrossRef PubMed.
  4. F. Yu, Y. Chen, H. Jiang and X. Wang, Analyst, 2020, 145, 6769–6812 RSC.
  5. D. Parmar, E. Sugiono, S. Raja and M. Rueping, Chem. Rev., 2014, 114, 9047–9153 CrossRef PubMed.
  6. Y.-B. Wang and B. Tan, Acc. Chem. Res., 2018, 51, 534–547 CrossRef PubMed.
  7. E. M. da Silva, H. D. A. Vidal, M. A. P. Januário and A. G. Corrêa, Molecules, 2023, 28, 12 CrossRef PubMed.
  8. J. Gao, J. H. Reibenspies and A. E. Martell, Angew. Chem., Int. Ed., 2003, 42, 6008–6012 CrossRef PubMed.
  9. J.-M. Tian, A.-F. Wang, J.-S. Yang, X.-J. Zhao, Y.-Q. Tu, S.-Y. Zhang and Z.-M. Chen, Angew. Chem., Int. Ed., 2019, 58, 11023–11027 CrossRef PubMed.
  10. J. Gao, P. Wang, A. Shen, X. Yang, S. Cen and Z. Zhang, ACS Catal., 2024, 14, 5621–5629 CrossRef.
  11. M. Nakajima, I. Miyoshi, K. Kanayama, S.-i. Hashimoto, M. Noji and K. Koga, J. Org. Chem., 1999, 64, 2264–2271 CrossRef.
  12. S. K. Alamsetti, E. Poonguzhali, D. Ganapathy and G. Sekar, Adv. Synth. Catal., 2013, 355, 2803–2808 CrossRef.
  13. Z. Luo, Q. Liu, L. Gong, X. Cui, A. Mi and Y. Jiang, Angew. Chem., Int. Ed., 2002, 41, 4532–4535 CrossRef.
  14. S. Takizawa, T. Katayama and H. Sasai, Chem. Commun., 2008, 44, 4113–4122 RSC.
  15. Q.-X. Guo, Z.-J. Wu, Z.-B. Luo, Q.-Z. Liu, J.-L. Ye, S.-W. Luo, L.-F. Cun and L.-Z. Gong, J. Am. Chem. Soc., 2007, 129, 13927–13938 CrossRef PubMed.
  16. H. Y. Kim, S. Takizawa, H. Sasai and K. Oh, Org. Lett., 2017, 19, 3867–3870 CrossRef PubMed.
  17. N. B. Barhate and C.-T. Chen, Org. Lett., 2002, 4, 2529–2532 CrossRef PubMed.
  18. T. Horibe, K. Nakagawa, T. Hazeyama, K. Takeda and K. Ishihara, Chem. Commun., 2019, 55, 13677–13680 RSC.
  19. H. Egami, K. Matsumoto, T. Oguma, T. Kunisu and T. Katsuki, J. Am. Chem. Soc., 2010, 132, 13633–13635 CrossRef PubMed.
  20. H. Egami and T. Katsuki, J. Am. Chem. Soc., 2009, 131, 6082–6083 CrossRef PubMed.
  21. S. Narute, R. Parnes, F. D. Toste and D. Pappo, J. Am. Chem. Soc., 2016, 138, 16553–16560 CrossRef PubMed.
  22. H. Hayashi, T. Ueno, C. Kim and T. Uchida, Org. Lett., 2020, 22, 1469–1474 CrossRef PubMed.
  23. R. Irie, K. Masutani and T. Katsuki, Synlett, 2000, 10, 1433–1436 Search PubMed.
  24. Z. Zhu, Y. Li, S. Ma, X. Zhou, Y. Huang, J. Sun and W.-Y. Ding, J. Org. Chem., 2024, 89, 16185–16194 CrossRef PubMed.
  25. D. Song, W. Huang, W. Zhang, C. Zheng, Y. Chen, J. Lv, C. Zheng, W. Zhong and F. Ling, J. Am. Chem. Soc., 2025, 147, 7524–7532 CrossRef PubMed.
  26. B. A. Jones, T. Balan, J. D. Jolliffe, C. D. Campbell and M. D. Smith, Angew. Chem., Int. Ed., 2019, 58, 4596–4600 CrossRef PubMed.
  27. J. Wencel-Delord, A. Panossian, F. R. Leroux and F. Colobert, Chem. Soc. Rev., 2015, 44, 3418–3430 RSC.
  28. R. Pearce-Higgins, L. N. Hogenhout, P. J. Docherty, D. M. Whalley, P. Chuentragool, N. Lee, N. Y. S. Lam, T. M. McGuire, D. Valette and R. J. Phipps, J. Am. Chem. Soc., 2022, 144, 15026–15032 CrossRef PubMed.
  29. H. Qiu, B. Shuai, Y.-Z. Wang, D. Liu, Y.-G. Chen, P.-S. Gao, H.-X. Ma, S. Chen and T.-S. Mei, J. Am. Chem. Soc., 2020, 142, 9872–9878 CrossRef PubMed.
  30. A. K. Yudin, L. J. P. Martyn, S. Pandiaraju, J. Zheng and A. Lough, Org. Lett., 2000, 2, 41–44 CrossRef PubMed.
  31. A. E. Metz, E. E. Podlesny, P. J. Carroll, A. N. Klinghoffer and M. C. Kozlowski, J. Am. Chem. Soc., 2014, 136, 10601–10604 CrossRef PubMed.
  32. T. Matsuno, Y. Koyama, S. Hiroto, J. Kumar, T. Kawai and H. Shinokubo, Chem. Commun., 2015, 51, 4607–4610 RSC.
  33. K. Yamamoto, K. Noda and Y. Okamoto, J. Chem. Soc., Chem. Commun., 1985, 1065–1066 RSC.
  34. V. N. Khose, M. Hasan, S. C. Khot, S. M. Mobin, V. Borovkov and A. V. Karnik, J. Org. Chem., 2020, 85, 1847–1860 CrossRef CAS PubMed.
  35. H. R. Talele, S. Sahoo and A. V. Bedekar, Org. Lett., 2012, 14, 3166–3169 CrossRef CAS PubMed.
  36. M. Sakai, A. Imayoshi, T. Sasamori, K. Okada, Y. Imai, M. Hasegawa and K. Tsubaki, ChemRxiv, 2024, 1–11 Search PubMed.
  37. A. K. Swain, K. Radacki, H. Braunschweig and P. Ravat, J. Org. Chem., 2022, 87, 993–1000 CrossRef CAS PubMed.
  38. B. M. Gross and M. Oestreich, Synthesis, 2021, 53, 2512–2516 CrossRef CAS.
  39. M. Shyam Sundar and A. V. Bedekar, Org. Lett., 2015, 17, 5808–5811 CrossRef CAS PubMed.
  40. A. k. Swain, K. Kolanji, C. Stapper and P. Ravat, Org. Lett., 2021, 23, 1339–1343 CrossRef CAS PubMed.
  41. V. Terrasson, M. Roy, S. Moutard, M.-P. Lafontaine, G. Pèpe, G. Félix and M. Gingras, RSC Adv., 2014, 4, 32412–32414 RSC.
  42. R. Gupta, T. A. Cabreros, G. Muller and A. V. Bedekar, Eur. J. Org Chem., 2018, 5397–5405 CrossRef CAS PubMed.
  43. M. S. Sundar, B. Klepetářová, L. Bednárová and G. Muller, Eur. J. Org Chem., 2021, 146–150 CrossRef CAS.
  44. S. Takizawa, J. Kodera, Y. Yoshida, M. Sako, S. Breukers, D. Enders and H. Sasai, Tetrahedron, 2014, 70, 1786–1793 CrossRef CAS.
  45. M. Sako, Y. Takeuchi, T. Tsujihara, J. Kodera, T. Kawano, S. Takizawa and H. Sasai, J. Am. Chem. Soc., 2016, 138, 11481–11484 CrossRef CAS PubMed.
  46. A. I. Meyers and K. A. Lutomski, J. Am. Chem. Soc., 1982, 104, 879–881 CrossRef CAS.
  47. T. Qin, S. L. Skraba-Joiner, Z. G. Khalil, R. P. Johnson, R. J. Capon and J. A. Porco, Nat. Chem., 2015, 7, 234–240 CrossRef CAS PubMed.
  48. H. Forkosh, V. Vershinin, H. Reiss and D. Pappo, Org. Lett., 2018, 20, 2459–2463 CrossRef CAS PubMed.
  49. G. Bringmann, T. Gulder, T. A. M. Gulder and M. Breuning, Chem. Rev., 2011, 111, 563–639 CrossRef CAS PubMed.
  50. C. I. Grove, M. J. Di Maso, F. A. Jaipuri, M. B. Kim and J. T. Shaw, Org. Lett., 2012, 14, 4338–4341 CrossRef CAS PubMed.
  51. J. Rae, J. Frey, S. Jerhaoui, S. Choppin, J. Wencel-Delord and F. Colobert, ACS Catal., 2018, 8, 2805–2809 CrossRef CAS.
  52. V. S. Raut, M. Jean, N. Vanthuyne, C. Roussel, T. Constantieux, C. Bressy, X. Bugaut, D. Bonne and J. Rodriguez, J. Am. Chem. Soc., 2017, 139, 2140–2143 CrossRef CAS PubMed.
  53. X. Bao, J. Rodriguez and D. Bonne, Chem. Sci., 2020, 11, 403–408 RSC.
  54. P. Liu, X. Bao, J.-V. Naubron, S. Chentouf, S. Humbel, N. Vanthuyne, M. Jean, L. Giordano, J. Rodriguez and D. Bonne, J. Am. Chem. Soc., 2020, 142, 16199–16204 CrossRef CAS PubMed.
  55. A. Gaucherand, E. Yen-Pon, D. García-López, J.-V. Naubron, S. Chentouf, M. Giorgi, S. Humbel, M. Jean, J. Rodriguez and D. Bonne, Chem. Sci., 2024, 15, 7300–7307 RSC.
  56. A. Domain, G. Bai, J.-C. Castillo, H. M. Abdraman, S. Humbel, M. Giorgi, J.-V. Naubron, S. Chentouf, J. Rodriguez, X. Bao and D. Bonne, Angew. Chem., Int. Ed., 2025, 64, e202506810 CrossRef CAS PubMed.
  57. A. Domain, X. Bao, J. Rodriguez and D. Bonne, Chem.–Eur. J., 2024, 30, e202403374 CrossRef CAS PubMed.
  58. H.-H. Zhang, T.-Z. Li, S.-J. Liu and F. Shi, Angew. Chem., Int. Ed., 2024, 63, e202311053 CrossRef CAS PubMed.
  59. A. Gaucherand, E. Yen-Pon, A. Domain, A. Bourhis, J. Rodriguez and D. Bonne, Chem. Soc. Rev., 2024, 53, 11165–11206 RSC.
  60. J. P. Vigneron, M. Dhaenens and A. Horeau, Tetrahedron, 1973, 29, 1055–1059 CrossRef CAS.
  61. J. Merad, P. Borkar, F. Caijo, J.-M. Pons, J.-L. Parrain, O. Chuzel and C. Bressy, Angew. Chem., Int. Ed., 2017, 56, 16052–16056 CrossRef CAS.
  62. (a) Y. Yang, G. Bai, M. Qin, J. Wang, Y. Yang, H. Wang, D. Bonne, J. Rodriguez and X. Bao, CCDC 2464854: Experimental Crystal Determination, 2025,  DOI:10.5517/ccdc.csd.cc2nqwfq; (b) Y. Yang, G. Bai, M. Qin, J. Wang, Y. Yang, H. Wang, D. Bonne, J. Rodriguez and X. Bao, CCDC 2464855: Experimental Crystal Determination, 2025,  DOI:10.5517/ccdc.csd.cc2nqwgr; (c) Y. Yang, G. Bai, M. Qin, J. Wang, Y. Yang, H. Wang, D. Bonne, J. Rodriguez and X. Bao, CCDC 2464856: Experimental Crystal Determination, 2025,  DOI:10.5517/ccdc.csd.cc2nqwhs; (d) Y. Yang, G. Bai, M. Qin, J. Wang, Y. Yang, H. Wang, D. Bonne, J. Rodriguez and X. Bao, CCDC 2464857: Experimental Crystal Determination, 2025,  DOI:10.5517/ccdc.csd.cc2nqwjt.
  63. Y. Wang, Z.-G. Wu and F. Shi, Chem Catal., 2022, 2, 3077–3111 CAS.
  64. W. Liu, T. Qin, W. Xie and X. Yang, Chem.–Eur. J., 2022, 28, e202202369 CrossRef CAS PubMed.
  65. D. Sue, T. Kawabata, T. Sasamori, N. Tokitoh and K. Tsubaki, Org. Lett., 2010, 12, 256–258 CrossRef CAS.
  66. L.-L. Han, Y.-M. Cui, Q. Yang, L.-L. Fang and L.-W. Xu, Angew. Chem., Int. Ed., 2022, 61, e202211922 CrossRef CAS PubMed.
  67. R. Kasahara, T. Toyoda, S. Fukasawa, A. Takeuchi, A. Sato, A. Hori and O. Kitagawa, Org. Lett., 2023, 25, 7390–7394 CrossRef CAS PubMed.
  68. A. Mondal, N. O. Thiel, R. Dorel and B. L. Feringa, Nat. Catal., 2022, 5, 10–19 CrossRef CAS.
  69. P. Wang, J. Wang, L. Wang, D. Li, K. Wang, Y. Liu, H. Zhu, X. Liu, D. Yang and R. Wang, Adv. Synth. Catal., 2018, 360, 401–405 CrossRef CAS.
  70. D. Campolo, S. Gastaldi, C. Roussel, M. P. Bertrand and M. Nechab, Chem. Soc. Rev., 2013, 42, 8434–8466 RSC.
  71. L. Yang, H. Zheng, L. Luo, J. Nan, J. Liu, Y. Wang and X. Luan, J. Am. Chem. Soc., 2015, 137, 4876–4879 CrossRef CAS.
  72. K.-X. Kong, T. Zhou, W.-K. Yuan, X.-S. Hui, Y. Li and B.-F. Shi, ACS Catal., 2025, 15, 4280–4286 CrossRef.
  73. Z.-S. Liu, Y. Hua, Q. Gao, Y. Ma, H. Tang, Y. Shang, H.-G. Cheng and Q. Zhou, Nat. Catal., 2020, 3, 727–733 CrossRef CAS.
  74. H. Nakahara and J. Yamaguchi, Org. Lett., 2022, 24, 8083–8087 CrossRef CAS PubMed.
  75. I. S. Mekeda, R. Y. Balakhonov and V. Z. Shirinian, Org. Biomol. Chem., 2024, 22, 7715–7724 RSC.
  76. See Fig. S6 in the SI.

Footnote

These authors contributed equally to this work.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.